The rapid evolution of AI has facilitated innovative solutions in analysing different biomedical imaging modalities. By leveraging the complementary information from each modality, multimodal AI solutions have shown a huge potential to go beyond human capabilities and offer advances in bioimaging. At the same time, new foundation models and transformer-based architectures are now poised to address unsolved challenges in this field. This review aims to explore and discuss the state-of-the-art AI techniques applied in multimodal biomedical imaging, presenting the key challenges and future directions. We discuss several integration strategies to combine multiple biomedical imaging data types. We also focus on methods to overcome the open challenges related to data quality, model interpretability, and ethical implications.
Multi-layer Complex networks are commonly used for modeling and analysing biological entities. This paper presents the advantage of using COMBO (Combining Multi Bio Omics) to suggest a new role of the chromosomal aberration as a cancer driver factor. Exploiting the heterogeneous multi-layer networks, COMBO integrates gene expression and DNA-methylation data in order to identify complex bilateral relationships between transcriptome and epigenome. We evaluated the multi-layer networks generated by COMBO on different TCGA cancer datasets (COAD, BLCA, BRCA, CESC, STAD) focusing on the effect of a specific chromosomal numerical aberration, broad gain in chromosome 20, on different cancer histotypes. In addition, the effect of chromosome 8q amplification was tested in the same TCGA cancer dataset. The results demonstrate the ability of COMBO to identify the chromosome 20 amplification cancer driver force in the different TCGA Pan Cancer project datasets.